{"id":730123,"date":"2023-02-09T08:08:03","date_gmt":"2023-02-09T13:08:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/"},"modified":"2023-02-09T08:08:03","modified_gmt":"2023-02-09T13:08:03","slug":"rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/","title":{"rendered":"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWARK, Calif., Feb.  09, 2023  (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Citi Virtual Oncology Leadership Summit on Tuesday, February 21, 2023, at 12:00 p.m. ET, being held virtually.<\/p>\n<p>A live webcast of the fireside chat can be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hVBmdPOZAwgMabtC-6T3tsfAZvptQUXWpPy84fmmHMlG_Gc6Kr6cBozw3jlwfMMvW7mC5-wBNdfUn9IquzKJJ5kHex3RAczwwOXZ55VI7nWepoOpl50bDDPTah--QaEqTJ2LuN8OA3u-xZ0bBC5b0g==\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. A replay of the event will be available on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ULR5I3RlE0dgRnnqXl3sXhoaRI9BQGACx4Fl2cIEcWB9EzVhnLELSukaafa7JBNkoGSl_H5qMtz8Pwtze6nfjQ==\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a>\u201d section of the Rain website after the conclusion of the event and will be archived on the Rain website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e2TgASRzooOKJxfZcyWnyNv-d4a1y4nDPcWybmmiuz0iwEklGE_kxyzk4hX1_vXCJ8XixMo6stSmuWt4F6tGGybRlDO-ElQU17OtG7fFLXc=\" rel=\"nofollow noopener\" target=\"_blank\">www.rainoncology.com<\/a>.<\/p>\n<p>\n        <strong>About Rain Oncology Inc.<\/strong><br \/>\n        <br \/>Rain Oncology Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors\u2019 underlying genetics rather than histology. Rain\u2019s lead product candidate, milademetan, is a small molecule, oral inhibitor of the p53-MDM2 complex that reactivates p53. In addition to milademetan, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.<\/p>\n<p>\n        <strong>Media Contact <\/strong><br \/>\n        <br \/>Jordyn Temperato <br \/>LifeSci Communications <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r070M0iXvRFqXlRNaE-q9A47xDFfaku1oZM-YBIlVHawIHJXNbqPOYyovgrT9uYag4y830dobo7iXcOX9-bsDXbBY-ilSk_UPsFQsp9OvAj3uSWjTrmwxpJg7Kk5k0A9\" rel=\"nofollow noopener\" target=\"_blank\">jtemperato@lifescicomms.com<\/a><\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Dan Ferry<br \/>LifeSci Advisors<br \/>+1.617.430.7576<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hMXN4b3IrlPtNtDxYQhGH9JuIGGCT6S5o7_-VMlB3lCUIdPXO-7kxce4_rbqxzB-5Vut9hxpwu97rJ0D9_kEm2RmM9FBTbzKfNPlAyT5qjsvuPyxa6c_bQqtLneb15-w\" rel=\"nofollow noopener\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTQxZDkyM2ItNzdmMi00MTE1LWE5OWUtNzI2YzllNjNhMWY1LTUwMDA0ODY0MQ==\/tiny\/Rain-Oncology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWARK, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Citi Virtual Oncology Leadership Summit on Tuesday, February 21, 2023, at 12:00 p.m. ET, being held virtually. A live webcast of the fireside chat can be accessed here. A replay of the event will be available on the \u201cEvents\u201d section of the Rain website after the conclusion of the event and will be archived on the Rain website at www.rainoncology.com. About Rain &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-730123","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Citi Virtual Oncology Leadership Summit on Tuesday, February 21, 2023, at 12:00 p.m. ET, being held virtually. A live webcast of the fireside chat can be accessed here. A replay of the event will be available on the \u201cEvents\u201d section of the Rain website after the conclusion of the event and will be archived on the Rain website at www.rainoncology.com. About Rain &hellip; Continue reading &quot;Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-09T13:08:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit\",\"datePublished\":\"2023-02-09T13:08:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/\",\"name\":\"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==\",\"datePublished\":\"2023-02-09T13:08:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/","og_locale":"en_US","og_type":"article","og_title":"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit - Market Newsdesk","og_description":"NEWARK, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) &#8212; Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Citi Virtual Oncology Leadership Summit on Tuesday, February 21, 2023, at 12:00 p.m. ET, being held virtually. A live webcast of the fireside chat can be accessed here. A replay of the event will be available on the \u201cEvents\u201d section of the Rain website after the conclusion of the event and will be archived on the Rain website at www.rainoncology.com. About Rain &hellip; Continue reading \"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-09T13:08:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit","datePublished":"2023-02-09T13:08:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/","name":"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==","datePublished":"2023-02-09T13:08:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NDQyOCM1Mzk2MjA2IzUwMDA0ODY0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-oncology-to-participate-in-the-2023-citi-virtual-oncology-leadership-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/730123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=730123"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/730123\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=730123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=730123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=730123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}